FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
wherein R1 is selected from compounds
(1) (2) (3), which are used for the manufacture and delivery of conjugated groups, such as small molecules, peptides, nucleic acids, fluorescent groups and polymers crosslinked with antagonists of integrin LFA-1 for targeted delivery to cells expressing LFA-1.
EFFECT: improved properties.
21 cl, 6 dwg, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3 | 2013 |
|
RU2623441C2 |
CONJUGATES FOR INTEGRIN ANTAGONIST TARGETED DELIVERY TO CELLS, EXPRESSING LFA-1 | 2013 |
|
RU2624731C2 |
PYRAZOLO[1,5-a]PYRIMIDINE AND THIENO[3,2-b]PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK-4 | 2011 |
|
RU2604062C2 |
DERIVATIVES OF DIHYDROBENZODIAZEPIN-2-ONE FOR TREATMENT OF NEUROLOGICAL DISORDERS | 2003 |
|
RU2315764C2 |
1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-HETEROCYCLYL-CARBOXAMIDE DERIVATIVES | 2013 |
|
RU2644761C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2011 |
|
RU2582235C2 |
HERBICIDE AGENT BASED ON ARYLSULFONYLAMINOCARBONYLTRIAZOLINONES | 1997 |
|
RU2240691C2 |
BENZYLAMINE DERIVATIVES AS INHIBITORS OF PLASMA KALLIKREIN | 2012 |
|
RU2607045C2 |
METHOD FOR IDENTIFICATION OF ANTI-TUMOR TARGET ENZYMES | 2002 |
|
RU2319482C2 |
Authors
Dates
2017-07-06—Published
2013-01-24—Filed